Evidence map›Paper›PMID 21575989›Full record

ArticlePlacenta2011

Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).

O Parolini, F Alviano, A G Betz, D W Bianchi, C Götherström, U Manuelpillai, A L Mellor, R Ofir, P Ponsaerts, S A Scherjon and 4 more

Open access · greenAbstract readConference Proceedings
In one paragraph

Article in Placenta, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 14 institutions in 9 countries.

O ParoliniCentro di Ricerca E. Menni, Fondazione Poliambulanza-Istituto Ospedaliero, Brescia, Italy.
F Alviano
A G Betz
D W Bianchi
C Götherström
U Manuelpillai
A L Mellor
R Ofir
P Ponsaerts
S A Scherjon
M L Weiss
S Wolbank
K J Wood
C V Borlongan
Augusta University · USAustrian Cluster for Tissue Regeneration · ATFondazione Poliambulanza Istituto Ospedaliero · ITJohn Radcliffe Hospital · GBKansas State University · USKarolinska University Hospital · SELeiden University Medical Center · NLMedical Research Council · GBMonash Institute of Medical Research · AUPluristem Therapeutics (Israel) · ILTufts Medical Center · USUniversity of Antwerp · BEUniversity of Bologna · ITUniversity of South Florida · US

Funding

Regulation of T cell immunity by indol 2,3 dioxygenaseR01HD041187 · NICHD · MEDICAL COLLEGE OF GEORGIA (MCG) · PI MELLOR, ANDREW LEE · 2002 to 2006
$1.6M
NEURAL CIRCUITRY OF THE KIDNEYR01NS034160 · NINDS · KANSAS STATE UNIVERSITY · PI WEISS, MARK L · 1997 to 2006
$1.3M
Medical Research Council MC_U105184296NICHD NIH HHS R01 HD041187NINDS NIH HHS R01 NS034160
6 · The paper itself

Abstract

The International Placenta Stem Cell Society (IPLASS) was founded in June 2010. Its goal is to serve as a network for advancing research and clinical applications of stem/progenitor cells isolated from human term placental tissues, including the amnio-chorionic fetal membranes and Wharton's jelly. The commitment of the Society to champion placenta as a stem cell source was realized with the inaugural meeting of IPLASS held in Brescia, Italy, in October 2010. Officially designated as an EMBO-endorsed scientific activity, international experts in the field gathered for a 3-day meeting, which commenced with "Meet with the experts" sessions, IPLASS member and board meetings, and welcome remarks by Dr. Ornella Parolini, President of IPLASS. The evening's highlight was a keynote plenary lecture by Dr. Diana Bianchi. The subsequent scientific program consisted of morning and afternoon oral and poster presentations, followed by social events. Both provided many opportunities for intellectual exchange among the 120 multi-national participants. This allowed a methodical and deliberate evaluation of the status of placental cells in research in regenerative and reparative medicine. The meeting concluded with Dr. Parolini summarizing the meeting's highlights. This further prepared the fertile ground on which to build the promising potential of placental cell research. The second IPLASS meeting will take place in September 2012 in Vienna, Austria. This meeting report summarizes the thought-provoking lectures delivered at the first meeting of IPLASS.

Indexed as

FemaleFetal Stem CellsFetusHumansPlacentaPregnancy

Identifiers

PMID21575989
PMCPMC4437622
OpenAlexW2097311920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.